Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
OXALIPLATIN
(2002)
Small molecule
DNA inhibitor
INJECTION; INTRAVENOUS
Approved
Unknown
OXALIPLATIN
×
Maximum Phase:
4
First Approval:
2002
UNII:
04ZR38536J
Molecule Type:
Small molecule
Molecular Formula:
C8H12N2O4Pt
Molecular Weight:
395.27
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
VORICONAZOLE
(2002)
Small molecule
Cytochrome P450 51 inhibitor
INJECTION; INTRAVENOUS; IV (INFUSION); ORAL
Approved
Aspergillosis; Candidemia; Candidiasis; Fusariosis; Infections
VORICONAZOLE
×
Maximum Phase:
4
First Approval:
2002
UNII:
JFU09I87TR
Molecule Type:
Small molecule
Molecular Formula:
C16H14F3N5O
Molecular Weight:
349.32
AlogP:
2.18
PSA:
76.72
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ELETRIPTAN
(2002)
Small molecule
Unknown
Unknown
Approved
Migraine Disorders
ELETRIPTAN
×
Maximum Phase:
4
First Approval:
2002
UNII:
22QOO9B8KI
Molecule Type:
Small molecule
Molecular Formula:
C22H26N2O2S
Molecular Weight:
382.53
AlogP:
3.82
PSA:
53.17
HBD:
1.0
HBA:
#RotB:
6.0
Source:
OXAPROZIN POTASSIUM
(2002)
Small molecule
Cyclooxygenase inhibitor
ORAL
Approved
Unknown
OXAPROZIN POTASSIUM
×
Maximum Phase:
4
First Approval:
2002
UNII:
ML56O2Z92I
Molecule Type:
Small molecule
Molecular Formula:
C18H14KNO3
Molecular Weight:
331.41
AlogP:
4.03
PSA:
63.33
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ESCITALOPRAM
(2002)
Small molecule
Unknown
Unknown
Approved
Depressive Disorder
ESCITALOPRAM
×
Maximum Phase:
4
First Approval:
2002
UNII:
4O4S742ANY
Molecule Type:
Small molecule
Molecular Formula:
C20H21FN2O
Molecular Weight:
324.4
AlogP:
3.81
PSA:
36.26
HBD:
0.0
HBA:
#RotB:
5.0
Source:
PERFLEXANE
(2002)
Small molecule
Unknown
Unknown
Approved
Unknown
PERFLEXANE
×
Maximum Phase:
4
First Approval:
2002
UNII:
FX3WJ41CMX
Molecule Type:
Small molecule
Molecular Formula:
C6F14
Molecular Weight:
338.04
AlogP:
4.65
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
3.0
Source:
ZIPRASIDONE MESYLATE
(2002)
Small molecule
Dopamine D2 receptor antagonist
INTRAMUSCULAR
Approved
Bipolar Disorder
ZIPRASIDONE MESYLATE
×
Maximum Phase:
4
First Approval:
2002
UNII:
3X6SAX83JZ
Molecule Type:
Small molecule
Molecular Formula:
C22H31ClN4O7S2
Molecular Weight:
563.1
AlogP:
3.81
PSA:
48.47
HBD:
1.0
HBA:
#RotB:
4.0
Source:
GUAIFENESIN
(2002)
Small molecule
Unknown
ORAL
Approved
Cough; Fever; Headache; Sinusitis
GUAIFENESIN
×
Maximum Phase:
4
First Approval:
2002
UNII:
495W7451VQ
Molecule Type:
Small molecule
Molecular Formula:
C10H14O4
Molecular Weight:
198.22
AlogP:
0.43
PSA:
58.92
HBD:
2.0
HBA:
#RotB:
5.0
Source:
EZETIMIBE
(2002)
Small molecule
Niemann-Pick C1-like protein 1 inhibitor
ORAL
Approved
Cardiovascular Diseases; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II
EZETIMIBE
×
Maximum Phase:
4
First Approval:
2002
UNII:
EOR26LQQ24
Molecule Type:
Small molecule
Molecular Formula:
C24H21F2NO3
Molecular Weight:
409.43
AlogP:
4.89
PSA:
60.77
HBD:
2.0
HBA:
#RotB:
6.0
Source:
ATOMOXETINE
(2002)
Small molecule
Unknown
Unknown
Approved
Attention Deficit Disorder with Hyperactivity
ATOMOXETINE
×
Maximum Phase:
4
First Approval:
2002
UNII:
ASW034S0B8
Molecule Type:
Small molecule
Molecular Formula:
C17H21NO
Molecular Weight:
255.36
AlogP:
3.72
PSA:
21.26
HBD:
1.0
HBA:
#RotB:
6.0
Source:
ARIPIPRAZOLE
(2002)
Small molecule
Dopamine D2 receptor partial agonist
INTRAMUSCULAR; ORAL; ORALLY DISINTEGRATING
Approved
Aggression; Autistic Disorder; Bipolar Disorder; Depressive Disorder; Depressive Disorder, Major; Psychomotor Agitation; Psychotic Disorders; Schizophrenia
ARIPIPRAZOLE
×
Maximum Phase:
4
First Approval:
2002
UNII:
82VFR53I78
Molecule Type:
Small molecule
Molecular Formula:
C23H27Cl2N3O2
Molecular Weight:
448.39
AlogP:
4.86
PSA:
44.81
HBD:
1.0
HBA:
#RotB:
7.0
Source:
OLMESARTAN MEDOXOMIL
(2002)
Small molecule
Type-1 angiotensin II receptor antagonist
Unknown
Approved
Cardiovascular Diseases; Diabetes Mellitus; Heart Failure; Hypertension; Myocardial Infarction; Stroke
OLMESARTAN MEDOXOMIL
×
Maximum Phase:
4
First Approval:
2002
UNII:
6M97XTV3HD
Molecule Type:
Small molecule
Molecular Formula:
C29H30N6O6
Molecular Weight:
558.6
AlogP:
4.17
PSA:
162.16
HBD:
2.0
HBA:
#RotB:
10.0
Source:
FULVESTRANT
(2002)
Small molecule
Estrogen receptor antagonist
INTRAMUSCULAR
Approved
Breast Neoplasms; Neoplasms
FULVESTRANT
×
Maximum Phase:
4
First Approval:
2002
UNII:
22X328QOC4
Molecule Type:
Small molecule
Molecular Formula:
C32H47F5O3S
Molecular Weight:
606.78
AlogP:
8.68
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
14.0
Source:
OXYBATE
(2002)
Small molecule
Unknown
Unknown
Approved
Unknown
OXYBATE
×
Maximum Phase:
4
First Approval:
2002
UNII:
30IW36W5B2
Molecule Type:
Small molecule
Molecular Formula:
C4H8O3
Molecular Weight:
104.11
AlogP:
-0.16
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
3.0
Source:
TEGASEROD
(2002)
Small molecule
Unknown
Unknown
Approved
Constipation
TEGASEROD
×
Maximum Phase:
4
First Approval:
2002
UNII:
458VC51857
Molecule Type:
Small molecule
Molecular Formula:
C16H23N5O
Molecular Weight:
301.39
AlogP:
2.81
PSA:
85.29
HBD:
4.0
HBA:
#RotB:
7.0
Source:
TEGASEROD MALEATE
(2002)
Small molecule
Serotonin 4 (5-HT4) receptor partial agonist
ORAL
Approved
Constipation; Irritable Bowel Syndrome
TEGASEROD MALEATE
×
Maximum Phase:
4
First Approval:
2002
UNII:
E5XNT3RF5A
Molecule Type:
Small molecule
Molecular Formula:
C20H27N5O5
Molecular Weight:
417.47
AlogP:
2.81
PSA:
85.29
HBD:
4.0
HBA:
#RotB:
7.0
Source:
EPLERENONE
(2002)
Small molecule
Mineralocorticoid receptor antagonist
ORAL
Approved
Cardiovascular Diseases; Heart Failure; Hypertension; Myocardial Infarction; Stroke
EPLERENONE
×
Maximum Phase:
4
First Approval:
2002
UNII:
6995V82D0B
Molecule Type:
Small molecule
Molecular Formula:
C24H30O6
Molecular Weight:
414.5
AlogP:
3.12
PSA:
82.2
HBD:
0.0
HBA:
#RotB:
1.0
Source:
ELETRIPTAN HYDROBROMIDE
(2002)
Small molecule
Serotonin 1b (5-HT1b) receptor agonist
ORAL
Approved
Migraine Disorders
ELETRIPTAN HYDROBROMIDE
×
Maximum Phase:
4
First Approval:
2002
UNII:
M41W832TA3
Molecule Type:
Small molecule
Molecular Formula:
C22H27BrN2O2S
Molecular Weight:
463.44
AlogP:
3.82
PSA:
53.17
HBD:
1.0
HBA:
#RotB:
6.0
Source:
ESCITALOPRAM OXALATE
(2002)
Small molecule
Serotonin transporter inhibitor
ORAL
Approved
Anxiety; Anxiety Disorders; Depression; Depressive Disorder, Major
ESCITALOPRAM OXALATE
×
Maximum Phase:
4
First Approval:
2002
UNII:
5U85DBW7LO
Molecule Type:
Small molecule
Molecular Formula:
C22H23FN2O5
Molecular Weight:
414.43
AlogP:
3.81
PSA:
36.26
HBD:
0.0
HBA:
#RotB:
5.0
Source:
ATOMOXETINE HYDROCHLORIDE
(2002)
Small molecule
Norepinephrine transporter inhibitor
ORAL
Approved
Attention Deficit Disorder with Hyperactivity
ATOMOXETINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2002
UNII:
57WVB6I2W0
Molecule Type:
Small molecule
Molecular Formula:
C17H22ClNO
Molecular Weight:
291.82
AlogP:
3.72
PSA:
21.26
HBD:
1.0
HBA:
#RotB:
6.0
Source:
HYDROQUINONE
(2002)
Small molecule
Unknown
Unknown
Approved
Hyperpigmentation; Lentigo; Melanosis
HYDROQUINONE
×
Maximum Phase:
4
First Approval:
2002
UNII:
XV74C1N1AE
Molecule Type:
Small molecule
Molecular Formula:
C6H6O2
Molecular Weight:
110.11
AlogP:
1.1
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
0.0
Source:
NITAZOXANIDE
(2002)
Small molecule
Pyruvate:ferredoxin oxidoreductase inhibitor
ORAL
Approved
Diarrhea
NITAZOXANIDE
×
Maximum Phase:
4
First Approval:
2002
UNII:
SOA12P041N
Molecule Type:
Small molecule
Molecular Formula:
C12H9N3O5S
Molecular Weight:
307.29
AlogP:
2.23
PSA:
111.43
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ADEFOVIR DIPIVOXIL
(2002)
Small molecule
DNA polymerase/reverse transcriptase inhibitor
ORAL
Approved
Hepatitis B, Chronic; Virus Diseases
ADEFOVIR DIPIVOXIL
×
Maximum Phase:
4
First Approval:
2002
UNII:
U6Q8Z01514
Molecule Type:
Small molecule
Molecular Formula:
C20H32N5O8P
Molecular Weight:
501.48
AlogP:
2.7
PSA:
166.98
HBD:
1.0
HBA:
#RotB:
11.0
Source:
TREPROSTINIL
(2002)
Small molecule
Prostanoid IP receptor agonist
INHALATION; INTRAVENOUS; IV (INFUSION); SUBCUTANEOUS
Approved
Hypertension, Pulmonary; Pulmonary Arterial Hypertension; Thrombosis
TREPROSTINIL
×
Maximum Phase:
4
First Approval:
2002
UNII:
RUM6K67ESG
Molecule Type:
Small molecule
Molecular Formula:
C23H34O5
Molecular Weight:
390.52
AlogP:
3.58
PSA:
86.99
HBD:
3.0
HBA:
#RotB:
10.0
Source:
SODIUM OXYBATE
(2002)
Small molecule
GABA-B receptor agonist
ORAL
Approved
Narcolepsy
SODIUM OXYBATE
×
Maximum Phase:
4
First Approval:
2002
UNII:
7G33012534
Molecule Type:
Small molecule
Molecular Formula:
C4H7NaO3
Molecular Weight:
126.09
AlogP:
-0.16
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
3.0
Source:
NITISINONE
(2002)
Small molecule
4-hydroxyphenylpyruvate dioxygenase inhibitor
ORAL
Approved
Unknown
NITISINONE
×
Maximum Phase:
4
First Approval:
2002
UNII:
K5BN214699
Molecule Type:
Small molecule
Molecular Formula:
C14H10F3NO5
Molecular Weight:
329.23
AlogP:
2.73
PSA:
94.35
HBD:
0.0
HBA:
#RotB:
3.0
Source:
FOSAMPRENAVIR CALCIUM
(2003)
Small molecule
Human immunodeficiency virus type 1 protease inhibitor
ORAL
Approved
Autoimmune Diseases; HIV Infections
FOSAMPRENAVIR CALCIUM
×
Maximum Phase:
4
First Approval:
2003
UNII:
ID1GU2627N
Molecule Type:
Small molecule
Molecular Formula:
C25H34CaN3O9PS
Molecular Weight:
623.68
AlogP:
2.52
PSA:
177.72
HBD:
4.0
HBA:
#RotB:
13.0
Source:
PALONOSETRON HYDROCHLORIDE
(2003)
Small molecule
Serotonin 3a (5-HT3a) receptor antagonist
INJECTION; INTRAVENOUS; ORAL
Approved
Nausea; Neoplasms; Postoperative Nausea and Vomiting; Vomiting
PALONOSETRON HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2003
UNII:
23310D4I19
Molecule Type:
Small molecule
Molecular Formula:
C19H25ClN2O
Molecular Weight:
332.88
AlogP:
2.66
PSA:
23.55
HBD:
0.0
HBA:
#RotB:
1.0
Source:
PAROXETINE MESYLATE
(2003)
Small molecule
Serotonin transporter inhibitor
ORAL
Approved
Unknown
PAROXETINE MESYLATE
×
Maximum Phase:
4
First Approval:
2003
UNII:
M711N184JE
Molecule Type:
Small molecule
Molecular Formula:
C20H24FNO6S
Molecular Weight:
425.48
AlogP:
3.33
PSA:
39.72
HBD:
1.0
HBA:
#RotB:
4.0
Source:
EPINASTINE HYDROCHLORIDE
(2003)
Small molecule
Histamine H1 receptor antagonist
OPHTHALMIC
Approved
Conjunctivitis, Allergic
EPINASTINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2003
UNII:
GFM415S5XL
Molecule Type:
Small molecule
Molecular Formula:
C16H16ClN3
Molecular Weight:
285.78
AlogP:
2.47
PSA:
41.62
HBD:
1.0
HBA:
#RotB:
0.0
Source:
TADALAFIL
(2003)
Small molecule
Phosphodiesterase 5A inhibitor
ORAL
Approved
Erectile Dysfunction; Hypertension, Pulmonary; Prostatic Hyperplasia; Pulmonary Arterial Hypertension
TADALAFIL
×
Maximum Phase:
4
First Approval:
2003
UNII:
742SXX0ICT
Molecule Type:
Small molecule
Molecular Formula:
C22H19N3O4
Molecular Weight:
389.41
AlogP:
2.21
PSA:
74.87
HBD:
1.0
HBA:
#RotB:
1.0
Source:
CARBINOXAMINE MALEATE
(2003)
Small molecule
Histamine H1 receptor antagonist
ORAL
Approved
Angioedema; Conjunctivitis, Allergic; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Rhinitis, Vasomotor; Urticaria
CARBINOXAMINE MALEATE
×
Maximum Phase:
4
First Approval:
2003
UNII:
02O55696WH
Molecule Type:
Small molecule
Molecular Formula:
C20H23ClN2O5
Molecular Weight:
406.87
AlogP:
3.4
PSA:
25.36
HBD:
0.0
HBA:
#RotB:
6.0
Source:
AMLODIPINE MALEATE
(2003)
Small molecule
Voltage-gated L-type calcium channel blocker
ORAL
Approved
Unknown
AMLODIPINE MALEATE
×
Maximum Phase:
4
First Approval:
2003
UNII:
CQ27G2BZJM
Molecule Type:
Small molecule
Molecular Formula:
C24H29ClN2O9
Molecular Weight:
524.95
AlogP:
2.27
PSA:
99.88
HBD:
2.0
HBA:
#RotB:
8.0
Source:
IBANDRONIC ACID
(2003)
Small molecule
Unknown
Unknown
Approved
Bone Diseases
IBANDRONIC ACID
×
Maximum Phase:
4
First Approval:
2003
UNII:
UMD7G2653W
Molecule Type:
Small molecule
Molecular Formula:
C9H23NO7P2
Molecular Weight:
319.23
AlogP:
0.5
PSA:
138.53
HBD:
5.0
HBA:
#RotB:
9.0
Source:
ATAZANAVIR SULFATE
(2003)
Small molecule
Human immunodeficiency virus type 1 protease inhibitor
ORAL
Approved
HIV Infections; Infections
ATAZANAVIR SULFATE
×
Maximum Phase:
4
First Approval:
2003
UNII:
4MT4VIE29P
Molecule Type:
Small molecule
Molecular Formula:
C38H54N6O11S
Molecular Weight:
802.95
AlogP:
4.21
PSA:
171.22
HBD:
5.0
HBA:
#RotB:
14.0
Source:
GEMIFLOXACIN
(2003)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
GEMIFLOXACIN
×
Maximum Phase:
4
First Approval:
2003
UNII:
OKR68Y0E4T
Molecule Type:
Small molecule
Molecular Formula:
C18H20FN5O4
Molecular Weight:
389.39
AlogP:
0.97
PSA:
123.04
HBD:
2.0
HBA:
#RotB:
5.0
Source:
1
2
…
52
53
54
55
56
57
58
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA